This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's What to Expect from Facebook (FB) Stock in 2019
by Benjamin Rains
Facebook's (FB) 2018 might be a year investors want to forget. But the social media powerhouse will hopefully use it as a lesson to help move forward. The question now is what should we expect from Facebook in 2019?
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Broadcom (AVGO) and CVS Health (CVS).
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.34 in the latest trading session, marking a -1.01% move from the prior day.
Why Is CVS Health (CVS) Up 0.2% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mixed Trade War Signals, the Moonves Scandal, & CVS' Drug Price Plan
by Ryan McQueeney
Ryan McQueeney discusses the latest drama in the U.S.-China trade war, new developments in Les Moonves' departure from CBS, and a new drug pricing plan from pharmacy giant CVS.
CVS Health (CVS) Stock Moves -0.77%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $78.91 in the latest trading session, marking a -0.77% move from the prior day.
Buy Walgreens (WBA) Stock on Expanded Kroger (KR) Partnership?
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) touched a new 52-week high Tuesday morning as investors began to digest the possibilities of what its partnership with grocery power Kroger (KR) might do to boost traffic as it expands its reach in the quickly changing retail age.
Should You Buy Kroger (KR) Stock Before Q3 Earnings?
by Benjamin Rains
Let's see what to expect from Kroger to understand if KR stock might be worth buying.
CVS Health Closes Aetna Deal, Focuses More on Pharmacy Wing
by Zacks Equity Research
The joint entity of CVS Health (CVS) and Aetna will provide customers with the powerful health resources of the former and the latter's network of providers for quality care.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $80.27, moving +0.97% from the previous trading session.